BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24920569)

  • 1. The alteration of the C-terminal region of human frataxin distorts its structural dynamics and function.
    Faraj SE; Roman EA; Aran M; Gallo M; Santos J
    FEBS J; 2014 Aug; 281(15):3397-419. PubMed ID: 24920569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function analysis of Friedreich's ataxia mutants reveals determinants of frataxin binding and activation of the Fe-S assembly complex.
    Bridwell-Rabb J; Winn AM; Barondeau DP
    Biochemistry; 2011 Aug; 50(33):7265-74. PubMed ID: 21776984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.
    Gomes CM; Santos R
    Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between activity and stability: Design and characterization of stable variants of human frataxin.
    Castro IH; Bringas M; Doni D; Noguera ME; Capece L; Aran M; Blaustein M; Costantini P; Santos J
    Arch Biochem Biophys; 2020 Sep; 691():108491. PubMed ID: 32707090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights on the conformational dynamics of human frataxin through modifications of loop-1.
    Noguera ME; Aran M; Smal C; Vazquez DS; Herrera MG; Roman EA; Alaimo N; Gallo M; Santos J
    Arch Biochem Biophys; 2017 Dec; 636():123-137. PubMed ID: 29097312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Frataxin Folds Via an Intermediate State. Role of the C-Terminal Region.
    Faraj SE; González-Lebrero RM; Roman EA; Santos J
    Sci Rep; 2016 Feb; 6():20782. PubMed ID: 26856628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics, stability and iron-binding activity of frataxin clinical mutants.
    Correia AR; Pastore C; Adinolfi S; Pastore A; Gomes CM
    FEBS J; 2008 Jul; 275(14):3680-90. PubMed ID: 18537827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An In Silico Analysis of Genetic Variants and Structural Modeling of the Human Frataxin Protein in Friedreich's Ataxia.
    Da Conceição LMA; Cabral LM; Pereira GRC; De Mesquita JF
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vivo mitochondrial two-step maturation of human frataxin.
    Schmucker S; Argentini M; Carelle-Calmels N; Martelli A; Puccio H
    Hum Mol Genet; 2008 Nov; 17(22):3521-31. PubMed ID: 18725397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Highly Conserved Iron-Sulfur Cluster Assembly Machinery between Humans and Amoeba
    Olmos J; Pignataro MF; Benítez Dos Santos AB; Bringas M; Klinke S; Kamenetzky L; Velazquez F; Santos J
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein stability and dynamics modulation: the case of human frataxin.
    Roman EA; Faraj SE; Gallo M; Salvay AG; Ferreiro DU; Santos J
    PLoS One; 2012; 7(9):e45743. PubMed ID: 23049850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frataxin mRNA isoforms in FRDA patients and normal subjects: effect of tocotrienol supplementation.
    Abruzzo PM; Marini M; Bolotta A; Malisardi G; Manfredini S; Ghezzo A; Pini A; Tasco G; Casadio R
    Biomed Res Int; 2013; 2013():276808. PubMed ID: 24175286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of frataxin "bypass" in human iron-sulfur cluster biosynthesis with implications for Friedreich's ataxia.
    Das D; Patra S; Bridwell-Rabb J; Barondeau DP
    J Biol Chem; 2019 Jun; 294(23):9276-9284. PubMed ID: 30975898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The factors governing the thermal stability of frataxin orthologues: how to increase a protein's stability.
    Adinolfi S; Nair M; Politou A; Bayer E; Martin S; Temussi P; Pastore A
    Biochemistry; 2004 Jun; 43(21):6511-8. PubMed ID: 15157084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Friedreich's ataxia: past, present and future.
    Marmolino D
    Brain Res Rev; 2011 Jun; 67(1-2):311-30. PubMed ID: 21550666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cis-silencing of PIP5K1B evidenced in Friedreich's ataxia patient cells results in cytoskeleton anomalies.
    Bayot A; Reichman S; Lebon S; Csaba Z; Aubry L; Sterkers G; Husson I; Rak M; Rustin P
    Hum Mol Genet; 2013 Jul; 22(14):2894-904. PubMed ID: 23552101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational stability of human frataxin and effect of Friedreich's ataxia-related mutations on protein folding.
    Correia AR; Adinolfi S; Pastore A; Gomes CM
    Biochem J; 2006 Sep; 398(3):605-11. PubMed ID: 16787388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches.
    Schmucker S; Puccio H
    Hum Mol Genet; 2010 Apr; 19(R1):R103-10. PubMed ID: 20413654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frataxin interacts with Isu1 through a conserved tryptophan in its beta-sheet.
    Leidgens S; De Smet S; Foury F
    Hum Mol Genet; 2010 Jan; 19(2):276-86. PubMed ID: 19884169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling Protein Plasticity: The Example of Frataxin and Its Variants.
    Botticelli S; La Penna G; Nobili G; Rossi G; Stellato F; Morante S
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.